Sana

Pain and mental health relief on demand

Sana

Company Details

Wearable light therapy that helps a broad range of pain and mental health disorders.

Sana is an FDA-designated Breakthrough device for fibromyalgia and is also in pivotal trials for neuropathic pain, and starting in Q1 2022 Anxiety. We also have a 1000 person Fibromyalgia study underway with the Mighty, the largest non0drug fibromyalgia study ever done. By the end of 2022, Sana will be established as a platform for treatment for pain and mental health.

  • Sana Company Video
  • Relieving Chronic Pain with Non-Invasive Bio-Therapeutics
  • Device

Company People

Steve Sanders

Steve Sanders
CFO

Richard Hanbury

Richard Hanbury
CEO & Co-Founder

Crystal George

Crystal George
VP Clinical Affairs 

Jeff Bower

Jeff Bower
VP Analytics

Sana News

VIEW ALL

You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.